Jazz Pharma (JAZZ) Tops Q3 EPS by 7c, Guides Above the Street
Tweet Send to a Friend
Jazz Pharma (Nasdaq: JAZZ) reports Q3 EPS of $0.41, 7 cents better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
